[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-350686-105":59,"doc-detail-350686-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","role-of-epithelial-mesenchymal-transition-emt-in-malignancies-current-status-and-future-prospects","Role of Epithelial-Mesenchymal Transition (EMT) in Malignancies - Current Status and Future Prospects","","Epithelial-mesenchymal transition (EMT) drives the conversion of epithelial cells into more mobile, invasive mesenchymal-like cells, supporting tumor proliferation, metastasis, and resistance to therapy. The review examines how EMT initiation and activation are shaped by extracellular cues, external substances, and pathological conditions such as hypoxia. EMT-associated cellular marker changes and signaling cascades are linked to invasion, migration, and evasion of immune responses via immunosuppressive pathways. Advances in experimental technologies enable deeper molecular mapping, biomarker discovery, and development of therapies that inhibit or reverse EMT to improve outcomes.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/role-of-epithelial-mesenchymal-transition-emt-in-malignancies-current-status-and-future-prospects/350686/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/role-of-epithelial-mesenchymal-transition-emt-in-malignancies-current-status-and-future-prospects/350686.png","ImageObject",300,407,{"name":92,"@type":93},"PakDamar76","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-07","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is epithelial-mesenchymal transition (EMT) in the context of cancer?","Question",{"text":112,"@type":113},"EMT is a biological program in which epithelial cells acquire more mobile, invasive mesenchymal-like traits. When aberrantly activated, it contributes to tumor invasion, metastasis, and therapy resistance.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Which factors can trigger EMT activation in malignancies?",{"text":117,"@type":113},"EMT induction can be triggered by various factors, including extracellular signals, external substances, and pathological conditions such as hypoxia.",{"name":119,"@type":110,"acceptedAnswer":120},"Why does targeting EMT matter for patient outcomes?",{"text":121,"@type":113},"Inhibiting EMT can restrict cancer cell invasion and metastasis and may improve therapeutic effectiveness. The review also highlights the potential to disrupt the cellular events and signaling cascades that drive EMT.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},350686,1790191041,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},962090893057,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","Signal Transduction [and Targeted Therapy](and Targeted Therapy www.nature.com/sigtrans)[ www.nature.com/sigtrans](and Targeted Therapy www.nature.com/sigtrans)  \nREVIEW ARTICLE OPEN  \nRole of epithelial-mesenchymal transition (EMT) in malignancies: current status and future prospects  \nVafa Meftahpour1 ✉ , Tikam Chand Dakal2, Jarek Maciaczyk3, Amit Sharma4 and Ingo G. H. Schmidt-Wolf4 ✉  \n\n|  | Epithelial-mesenchymal transition (EMT) is a biological process that involves the transformation of epithelial cells into more mobile and invasive mesenchymal cells. While EMT is crucial for typical physiological functions like maturation of the embryo and tissue restoration, its association with cancer often leads to tumor proliferation, metastasis, and resistance to therapy. This transition permits tumors to acquire traits that promote invasion, migration, and resistance to cell death. Therefore, unraveling the intricate mechanisms of EMT activation in cancer will contribute to the advancement of personalized medicine and the design of more effective treatments against metastatic disease. Inhibiting EMT holds the potential for restricting cancer cell invasion and metastasis, ultimately improving patient outcomes. EMT induction can be triggered by various factors, including extracellular signals, external substances, and pathological conditions such as hypoxia. This paper primarily examines the function of EMT in the initiation and progression of tumors, along with the factors that contribute to its activation. With the aid of cutting-edge technologies and improved experimental techniques, researchers can more effectively investigate the complex network of molecular events underlying EMT, leading to the identiﬁcation of novel biomarkers and the advancement of therapies. By leveraging these advancements, scientists are better equipped to unravel the intricacies of EMT and pave the way for advancements in personalized medicine and improved treatment strategies for patients affected by EMT-related conditions. Understanding the cellular events and signaling cascades that drive EMT can aid in the development of interventions that disrupt |  |\n| --- | --- | --- |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n| or reverse this process. |  |  |\n|  | Signal Transduction and Targeted Therapy (2026)11:334 ; [https://doi.org/10.1038/s41392-026-02881-4](https://doi.org/10.1038/s41392-026-02881-4) |  |\n|  |  |  |\n\nINTRODUCTION  \nEpithelial-mesenchymal transition (EMT) is a cell-biological program that contributes to tumor invasion and metastasis if it is aberrantly activated. Although EMT is commonly associated with the aggressive properties of carcinoma, its role extends beyond cancer progression. There is evidence supporting the correlation between EMT and autoimmune diseases, as well as ﬁbrosis.1,2 This suggests that the pathophysiology of autoimmune disorders and the emergence of ﬁbrotic illnesses may be inﬂuenced by EMT. Evidently, many biological processes, such as embryogenesis, tissue morphogenesis, and adult wound healing, depend critically on EMT. During embryogenesis, EMT is involved in gastrulation, which is the process of forming endoderm, mesoderm, and ectoderm that are vital in giving rise to different tissues and organs.3 In compliance with cancer, however, EMT is often activated, leading to the progression of malignancies and increased aggressiveness of cancer cells, which can permeate nearby tissues and travel to other parts of the body.4 As a result, the epithelial cells no longer have tightly connected characteristics and develop the migratory and invasive properties commonly observed in mesenchymal cells.5 Epithelial cells undergoing EMT also express speciﬁc markers associated with the non-epithelial cell state, the mesenchymal state. The markers,  \nwhich include neural cadherin (N-cadherin), together with vimentin and ﬁbronectin.6 ","cbCaiclKPAu6ODE1","https://ap.wps.com/l/cbCaiclKPAu6ODE1","pdf",6191501,35,"English","# Introduction\n## EMT as a driver of invasion and metastasis\n## EMT beyond cancer: autoimmune disease and fibrosis\n## EMT markers and signaling mechanisms","[{\"question\":\"What is epithelial-mesenchymal transition (EMT) in the context of cancer?\",\"answer\":\"EMT is a biological program in which epithelial cells acquire more mobile, invasive mesenchymal-like traits. When aberrantly activated, it contributes to tumor invasion, metastasis, and therapy resistance.\"},{\"question\":\"Which factors can trigger EMT activation in malignancies?\",\"answer\":\"EMT induction can be triggered by various factors, including extracellular signals, external substances, and pathological conditions such as hypoxia.\"},{\"question\":\"Why does targeting EMT matter for patient outcomes?\",\"answer\":\"Inhibiting EMT can restrict cancer cell invasion and metastasis and may improve therapeutic effectiveness. The review also highlights the potential to disrupt the cellular events and signaling cascades that drive EMT.\"}]","Role of Epithelial-Mesenchymal Transition (EMT) in Malignancies - Current Status and Future Prospects | PDF",1790090613,88,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c30be611738b55410e2b9f26eb70acce.webp",983,1305,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6960a2d1f518a186fba84a1da82f815a.webp",982,1304,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/62b07db53682ce0489ad70a84461ed0d.webp",981,1303,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a02252008c88221a8cd97a00726bde30.webp",980,1301]